1-(4-tetradecylphenoxy)-3-(triphenylmethoxy)-2-propanol | 90857-83-3

• 分子结构分类: 有机化合物 - 苯类化合物 - 三苯基化合物
• 英文名称: 1-(4-tetradecylphenoxy)-3-(triphenylmethoxy)-2-propanol
• 英文别名: 1-(4-tetradecylphenoxy)-3-trityloxypropan-2-ol
• CAS: 90857-83-3
• 化学式: C₄₂H₅₄O₃
• 分子量: 606.889
• InChiKey: UBFUADPQAGGCRJ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  13.1
• 重原子数：
  45
• 可旋转键数：
  22
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.43
• 拓扑面积：
  38.7
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  1-(4-tetradecylphenoxy)-3-(triphenylmethoxy)-2-propanol 在 水 、 sodium acetate 、 sodium hydride 、 对甲苯磺酸 、 三乙胺 、 N,N-二甲基甲酰胺 、 silver carbonate 作用下， 以 四氢呋喃 、 甲醇 、 N,N-二甲基甲酰胺 为溶剂， 反应 35.0h， 生成 4-hydroxy-N,N,N-trimethyl-9-phenyl-7-<(2-tetradecylphenoxy)methyl>-3,5,8-trioxa-4-phosphanonan-1-aminium 4-oxide, hydroxide, inner salt
  参考文献：
  名称：

  Analogs of platelet activating factor (PAF). 1. Some modifications of the alkoxy chain

  摘要：

  Analogues of platelet activating factor (PAF) in which the ether oxygen has been removed (6) and in which the alkoxy chain at C1 has been replaced with a o-, p-, or m-alkylphenoxy group (30, 31, and 35, respectively) have been prepared. Compound 6 shows reduced platelet aggregation and hypotensive activity in comparison with C16 and C18 PAF. The results obtained for compounds 30, 31, and 35 indicate that the hypotensive and platelet aggregating responses are sensitive to structural modification of the ether chain. The ortho analogue 30 shows no platelet aggregating activity and only a weak hypotensive response. The para analogue 31 exhibits a moderate decrease in activity in both assays. The meta analogue 35 is the most active of the three.

  DOI：

  10.1021/jm00375a016
• 作为产物：
  描述：

  4-十四烷基苯酚 在 吡啶 、 盐酸 、 sodium hydride 作用下， 以 甲醇 为溶剂， 反应 77.0h， 生成 1-(4-tetradecylphenoxy)-3-(triphenylmethoxy)-2-propanol
  参考文献：
  名称：

  Analogs of platelet activating factor (PAF). 1. Some modifications of the alkoxy chain

  摘要：

  Analogues of platelet activating factor (PAF) in which the ether oxygen has been removed (6) and in which the alkoxy chain at C1 has been replaced with a o-, p-, or m-alkylphenoxy group (30, 31, and 35, respectively) have been prepared. Compound 6 shows reduced platelet aggregation and hypotensive activity in comparison with C16 and C18 PAF. The results obtained for compounds 30, 31, and 35 indicate that the hypotensive and platelet aggregating responses are sensitive to structural modification of the ether chain. The ortho analogue 30 shows no platelet aggregating activity and only a weak hypotensive response. The para analogue 31 exhibits a moderate decrease in activity in both assays. The meta analogue 35 is the most active of the three.

  DOI：

  10.1021/jm00375a016

文献信息

• Phosphocholine derivatives having antihypertensive action
  申请人：American Cyanamid Company

  公开号：US04640913A1

  公开（公告）日：1987-02-03

  Phosphocholine derivatives and compositions are described which are useful as hypotensive agents and in the treatment of hypertension in warm-blooded animals.

  磷酸胆碱衍生物和组合物被描述为在温血动物中作为降压剂和治疗高血压的有用药物。
• US4640913A
  申请人：——

  公开号：US4640913A

  公开（公告）日：1987-02-03
• Analogs of platelet activating factor (PAF). 1. Some modifications of the alkoxy chain
  作者：A. Wissner、P. E. Sum、R. E. Schaub、C. A. Kohler、B. M. Goldstein

  DOI：10.1021/jm00375a016

  日期：1984.9

  Analogues of platelet activating factor (PAF) in which the ether oxygen has been removed (6) and in which the alkoxy chain at C1 has been replaced with a o-, p-, or m-alkylphenoxy group (30, 31, and 35, respectively) have been prepared. Compound 6 shows reduced platelet aggregation and hypotensive activity in comparison with C16 and C18 PAF. The results obtained for compounds 30, 31, and 35 indicate that the hypotensive and platelet aggregating responses are sensitive to structural modification of the ether chain. The ortho analogue 30 shows no platelet aggregating activity and only a weak hypotensive response. The para analogue 31 exhibits a moderate decrease in activity in both assays. The meta analogue 35 is the most active of the three.